Director, Analytical Biotechnology - BPD @ Global Head, Analytical Sciences incl Product Characterisation, Quality Control (QC), Stability, Potency & Process testing as part of Biopharmaceutical Development (BPD). Management of budgets & staff, global BPD and site R&D leadership teams. Cross-functional BPD lead for Cardiovascular & Metabolic Disease therapies, CMC project leadership and lead for various Biopharma Industry-Regulatory forums. [MedImmune is the Biologics R&D division of AstraZeneca]. From March 2009 to Present (6 years 10 months) Associate Director, PIC - Biotechnology @ Study director in protein chemistry, progressing to Associate Director & Dept Head, Protein and Immunochemistry - Biotechnology, with responsibilities incl: product-specific analytical method development & validation, cGMP batch release & stability testing, and product PK/TK, immunogenicity assessment, with experience of drug development for a wide range of different protein therapeutics from pre-clinical to commercial release. From May 2000 to December 2008 (8 years 8 months) Senior Scientist, Protein Chemistry @ Synthesis, modification, conjugation and characterisation of biotherapeutic proteins. From October 1998 to May 2000 (1 year 8 months) Research Scientist @ Research studies with Prof. Robin E. Offord on behaviour/fate human proteins, in collaboration with GSK Biologics and Serono. Tutor in Medical Biochemistry. Co-ordination of Clinical Research Programs. From October 1994 to October 1998 (4 years 1 month)

PhD, Protein Chemistry @ University of Cambridge Alistair Kippen is skilled in: Biopharmaceuticals, Biotechnology, GMP, Lifesciences, Technology Transfer, GLP, Validation, Pharmaceutical Industry, HPLC, Chromatography, Clinical Development, Vaccines, Drug Discovery, Protein Chemistry, R&D